Acadia Healthcare (NASDAQ:ACHC) Shares Down 6.2% – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares dropped 6.2% during mid-day trading on Wednesday . The company traded as low as $13.89 and last traded at $13.9360. Approximately 1,055,661 shares were traded during trading, a decline of 55% from the average daily volume of 2,326,890 shares. The stock had previously closed at $14.86.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on ACHC shares. Royal Bank Of Canada reduced their target price on shares of Acadia Healthcare from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 price target on Acadia Healthcare in a research report on Wednesday, December 3rd. Raymond James Financial set a $17.00 price objective on Acadia Healthcare in a research report on Wednesday, December 3rd. Leerink Partnrs lowered Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Finally, UBS Group cut their price target on Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $18.82.

Acadia Healthcare Trading Up 0.6%

The business has a 50 day moving average of $15.60 and a 200-day moving average of $20.31. The stock has a market cap of $1.25 billion, a PE ratio of 11.56, a price-to-earnings-growth ratio of 3.53 and a beta of 0.88. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The company had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Institutional Trading of Acadia Healthcare

Institutional investors have recently added to or reduced their stakes in the business. Caxton Associates LLP bought a new stake in shares of Acadia Healthcare in the 1st quarter valued at approximately $394,000. Envestnet Portfolio Solutions Inc. boosted its stake in Acadia Healthcare by 256.4% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after buying an additional 18,742 shares in the last quarter. Oppenheimer Asset Management Inc. grew its position in Acadia Healthcare by 85.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after acquiring an additional 13,188 shares during the period. Janney Montgomery Scott LLC acquired a new position in Acadia Healthcare during the second quarter worth $479,000. Finally, Truist Financial Corp lifted its holdings in shares of Acadia Healthcare by 85.6% during the second quarter. Truist Financial Corp now owns 82,741 shares of the company’s stock valued at $1,877,000 after acquiring an additional 38,167 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.